Home/Filings/4/0001830755-25-000009
4//SEC Filing

Hamilton James C 4

Accession 0001830755-25-000009

CIK 0000879407other

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 6:06 PM ET

Size

5.3 KB

Accession

0001830755-25-000009

Insider Transaction Report

Form 4
Period: 2025-09-12
Hamilton James C
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2025-09-12$30.00/sh15,000$450,000232,122 total
Footnotes (2)
  • [F1]Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  • [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.

Issuer

ARROWHEAD PHARMACEUTICALS, INC.

CIK 0000879407

Entity typeother

Related Parties

1
  • filerCIK 0001830755

Filing Metadata

Form type
4
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 6:06 PM ET
Size
5.3 KB